Clinical Trial Update: Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating weekly topotecan with bevacizumab in platinum-resistant/recurrent gynecologic cancers; the study (including ovarian, fallopian tube, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Topotecan (topotecan)

Snippet

Sponsor: Benaroya Research Institute | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-05-15